SELL and type 2 diabetes mellitus: Compared to the controls, however, the T2DM leukocytes demonstrated 31% increased expression of L-selectin (P = 0.015) and 61% increased CD44 (P = 0.032), with an increasing trend in both L-selectin and CD44 in the IFG patients (Fig 6B–6D).